首页 > Newsroom > Exhibition Recap:Sunrise Group in 2024 CPHI North America
Exhibition Recap:Sunrise Group in 2024 CPHI North America
2024-05-11

The CPHI North America grandly opened in Philadelphia, PA on May 7th. As the exclusive pharma event in the Americas covering the end-to-end supply chain, it is the only place to meet suppliers from all across pharma industry, including drug research and development, manufacturing, and packaging.

展会大厅.png

会场.png

The North American market stands as one of the dominant end markets for pharmaceutical ingredients, gearing up the future landscape of the pharmaceutical industry. This exhibition serves as an indispensable platform for fostering collaborations in the pharmaceutical field, offering invaluable networking opportunities and the exploration of international markets.

展台4.png

展台6 (1).png

未标题-1.png

Sunrise Group (At Booth #1000) has received numerous inquiries, many from foreigners interested in pharmaceutical raw materials and intermediates.


Sunrise Group’s international business team is actively involved in this industry event, showcasing comprehensive understanding and in-depth mapping of the chemical supply chain to clients. They also share the latest project cases and market trends that will shape the industry with forefront leaders.


Meanwhile, global competitiveness is becoming increasingly important for the pharmaceutical industry, Sunrise Group will continue to reinvent its business model in pharmaceutical R&D, contributing to the development of the global pharmaceutical industry.

公众号——CPHI罗总.png

公众号——CPHI超颖总.png

返回列表 > 
 < Sunrise Group Recognized 8th Among ICIS 2024 Global Top 100 Chemical Distributors Sunrise Group attended the 2024 Japan Convention on Pharmaceutical Ingredients > 
相关推荐
Spotlight on Sunrise Group at CPHI China 2024 Enhancing collaboration-Sunrise Group Visits Albemarle Dalian Shared Service Center Sunrise Group Recognized 8th Among ICIS 2024 Global Top 100 Chemical Distributors Sunrise Group attended the 2024 Japan Convention on Pharmaceutical Ingredients Fang Lijuan Assumes Role of CEO at Sunrise Fine Chemicals